Siponimod
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 326 publications
Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Intracerebral hemorrhage induces monocyte TNF signaling that is suppressed by Siponimod (BAF312): a single-cell transcriptomics study in patients.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review.
Journal: The Annals of pharmacotherapy
Published: January 03, 2026
Selective Activation of GPCRs: Molecular Dynamics Shows Siponimod Binds but Fails To Activate S1PR2, Unlike S1PR1.
Journal: Journal of chemical information and modeling
Published: December 04, 2025
Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes.
Journal: Acta neuropathologica
Published: November 24, 2025
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
Journal: Therapeutic advances in neurological disorders
Published: November 09, 2025
Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.
Journal: Frontiers in immunology
Published: October 28, 2025
Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia.
Journal: Frontiers in public health
Published: September 25, 2025
Cerebellar subregional atrophy in relapsing-remitting multiple sclerosis: Stage-dependent dynamics and pharmacological modulation.
Journal: Brain research bulletin
Published: September 13, 2025
Siponimod enhances brain-derived neurotrophic factor secretion from immune cells in multiple sclerosis: A longitudinal study.
Journal: Journal of the neurological sciences
Published: August 16, 2025
Effectiveness and safety of ofatumumab in treatment-naive and oral DMT-switched multiple sclerosis patients: a multicenter observational study in China.
Journal: Multiple sclerosis and related disorders
Published: July 31, 2025
Last Updated: 04/28/2026